These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28569624)

  • 1. Effectiveness of Parenteral Glutamine on Methotrexate-induced Oral Mucositis in Children with Acute Lymphoblastic Leukemia.
    Chang YH; Yu MS; Wu KH; Hsu MC; Chiou YH; Wu HP; Peng CT; Chao YH
    Nutr Cancer; 2017 Jul; 69(5):746-751. PubMed ID: 28569624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.
    Totadri S; Srinivasan HN; Joseph LL; Boddu D; Mathew LG; John R
    Pediatr Hematol Oncol; 2021 Aug; 38(5):434-443. PubMed ID: 33764242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is hypoalbuminemia a risk factor for high-dose methotrexate toxicity in children with acute lymphoblastic leukemia?
    Barakat S; Assem H; Salama M; Mikhael N; El Chazli Y
    J Egypt Natl Canc Inst; 2022 Apr; 34(1):17. PubMed ID: 35434757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
    Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
    Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?
    Dagdemir A; Yildirim H; Aliyazicioglu Y; Kanber Y; Albayrak D; Acar S
    Support Care Cancer; 2004 Apr; 12(4):263-7. PubMed ID: 14767751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with high dose methotrexate therapy in childhood acute lymphoblastic leukemia in a tertiary care cancer centre of a developing country.
    Kapoor G; Sinha R; Abedin S
    Pediatr Blood Cancer; 2012 Sep; 59(3):448-53. PubMed ID: 22271707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy Oral Glutamine to Prevent Oral Mucositis and Reduce Hospital Costs During Chemotherapy in Children with Acute Lymphoblastic Leukemia.
    Widjaja NA; Pratama A; Prihaningtyas R; Irawan R; Ugrasena I
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2117-2121. PubMed ID: 32711440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.
    Adam de Beaumais T; Dervieux T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):653-8. PubMed ID: 20033410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
    Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
    Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
    Oosterom N; Griffioen PH; den Hoed MAH; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
    PLoS One; 2018; 13(7):e0199574. PubMed ID: 29985926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
    Svahn T; Mellgren K; Harila-Saari A; Åsberg A; Kanerva J; Jónsson Ó; Vaitkeviciene G; Stamm Mikkelssen T; Schmiegelow K; Heldrup J
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia].
    Xu WQ; Tang YM; Fang CQ; Song H; Shi SW; Yang SL; Ren DT; Shen HQ; Qian BQ
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):15-8. PubMed ID: 15946502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer.
    Cheng KK
    Eur J Cancer Care (Engl); 2008 May; 17(3):306-11. PubMed ID: 18419635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
    Oosterom N; Dirks NF; Heil SG; de Jonge R; Tissing WJE; Pieters R; van den Heuvel-Eibrink MM; Heijboer AC; Pluijm SMF
    Support Care Cancer; 2019 Jan; 27(1):183-190. PubMed ID: 29922939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Intestinal Permeability by Measuring Plasma Endotoxin and Diamine Oxidase in Children with Acute Lymphoblastic Leukemia Treated with High-dose Methotrexate.
    Meng Y; Zhang Y; Liu M; Huang YK; Zhang J; Yao Q; Zhao YL; Xiong JJ
    Anticancer Agents Med Chem; 2016; 16(3):387-92. PubMed ID: 26265099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse effects of high-dose methotrexate therapy].
    Sun Q; Xie Y; Zhao WH; Hua Y; Wu PH; Li S; Lu XT
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jul; 19(7):781-785. PubMed ID: 28697831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia.
    Gutierrez-Camino A; Oosterom N; den Hoed MAH; Lopez-Lopez E; Martin-Guerrero I; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; Heil SG; García-Orad A; van den Heuvel-Eibrink MM
    Pharmacogenet Genomics; 2017 Aug; 27(8):303-306. PubMed ID: 28628559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study.
    Locasciulli A; Mura R; Fraschini D; Gornati G; Scovena E; Gervasoni A; Uderzo C; Masera G
    Haematologica; 1992; 77(1):49-53. PubMed ID: 1398282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study on elimination delay of methotrexate in high-dose therapy of childhood acute lymphoblastic leukemia in China.
    Xu W; Tang Y; Song H; Shi S; Yang S
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):688-93. PubMed ID: 17921849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral mucositis in paediatric acute lymphoblastic leukemia patients receiving methotrexate-based chemotherapy: case series.
    Garrocho-Rangel JA; Herrera-Moncada M; Márquez-Preciado R; Tejeda-Nava F; Ortiz-Zamudio JJ; Pozos-Guillén A
    Eur J Paediatr Dent; 2018 Sep; 19(3):239-242. PubMed ID: 30063158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.